Podcast Episode 82: Neuropsychological Evaluations for PD

PD Library thumbnail

Parkinson’s disease (PD) is much more than a movement disorder. It can have wide ranging effects throughout the body. In terms of the brain, people with PD may experience changes in cognition, mood, emotion, perception, attention, sleep, memory, motivation, and the senses, as well as drug-induced behavioral changes. One of the key professionals on a comprehensive PD treatment team is the neuropsychologist, a person with training and expertise in asking questions and administering screening and assessment tests to evaluate a person’s mental abilities and psychological state. Deficits in one or more of these areas can make it difficult to control motor symptoms such as tremor and balance.

Depending on the results of the evaluations, the neuropsychologist can work with other team members to implement therapies and teach strategies to improve the life of the person with PD. Also, it may be useful to have a neuropsychological evaluation early in the course of the disease to establish a baseline so that a neurologist can later determine if changes, especially in cognition, are related to medications, to progression of the PD itself, or to other factors such as depression. In this episode, Dr. Travis Turner, Director of the Division of Neuropsychology and chief liaison to the Movement Disorders Program at the Medical University of South Carolina in Charleston, a Parkinson’s Foundation Center of Excellence, discusses the role of the neuropsychologist, the process of neuropsychological evaluation, and some of the kinds of problems he deals with.

Download This Episode

Related Resources

About This Episode

Released: June 2, 2020

TurnerTravis H Turner, PhD

Travis H. Turner, PhD, is assistant professor and director of the Neuropsychology Division at the Medical University of South Carolina. He is also senior clinical director of Movement Disorders at VeraSci. He studied psychology and neuroscience at the University of Pittsburgh, earned his doctorate in clinical psychology through San Diego State University and the University of California, San Diego, and completed internship and postdoctoral training at MUSC. He has been active in clinical and research efforts with the Movement Disorders program for over 10 years. Clinical activities include neuropsychological evaluations and focused interventions for patients with Parkinson’s disease and related disorders. His research program is aimed at developing new ways to measure and treat neuropsychiatric symptoms in Parkinson's disease. Current projects include standardization of computerized behavioral saccade tests, neuropsychological assessment via videoconferencing (i.e., telemedicine), and clinical trials. He supervises neuropsychology postdoctoral fellows and provides training to graduate students, medical students, interns, and residents. When he’s not working, he enjoys fishing, building furniture, and spending time with his family.

This episode is supported by a grant from Genentech, a member of the Roche Group.

grant

Want More?

Don't forget to subscribe! There are many ways to listen: Apple PodcastsGoogle PlayTuneIn (Amazon Echo), Spotify or RSS Feed. (Need help subscribing? See our quick guide.)

For all of our Substantial Matters podcast episodes, visit parkinson.org/podcast.

X
 

Sign Up for Our E-Newsletter

Get the latest news about PD research, resources and community initiatives – straight to your inbox.

Please enter a valid email

Skip step



Invalid year format. Eg: 2020
Skip step
Skip step


*Please note that not all content is available in both languages. If you are interested in receiving Spanish communications, we recommend selecting “both" to stay best informed on the Foundation's work and the latest in PD news.

Skip step

Thanks for Signing Up

We are proud to have you as a part of our community. To ensure you receive the latest Parkinson’s news, research updates and more, please check your email for a message from us. If you do not see our email, it may be in your spam folder. Just mark as “not spam” and you should receive our emails as expected.

mail icon

Subscribe here to get the latest news on treatments, research and other updates.